Showing 1041-1050 of 18563 results for "".
Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025
https://reachmd.com/programs/cme/transformative-insights-latest-evidence-for-b7-h3-adcs-from-wclc-and-esmo-2025/36238/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
https://reachmd.com/programs/cme/ttr-levels-and-associated-disease-risk-insights-from-2025-pns-conference/36192/Review recent data from the UK Biobank showing the increased risk of vascular and cognitive comorbidities associated with naturally low transthyretin levels.Incorporating Targeted Therapies in Treatment Planning for AAV
https://reachmd.com/programs/cme/incorporating-targeted-therapies-in-treatment-planning-for-aav/14962/Our experts offer tips to effectively manage your patients with AAV & improve their quality of life by incorporating C5a receptor antagonist therapy.Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
https://reachmd.com/programs/cme/resectable-head-neck-cancer-a-team-based-approach-to-perioperative-immunotherapy/35705/Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative ImmunotherapyClinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
https://reachmd.com/programs/cme/employing-immunotherapy-and-adcs-in-advanced-endometrial-and-cervical-cancers-current-and-emerging-therapies/14460/Our experts are breaking down evolving treatments for advanced endometrial & cervical cancer. Hear the latest data on immunotherapy and ADCs now!Frontline Insights: Emerging Therapeutic Strategies in HNSCC
https://reachmd.com/programs/cme/Frontline-Insights-Emerging-Therapeutic-Strategies-in-HNSCC/49223/Review emerging therapeutic strategies in HNSCC across disease states and learn to compare safety profile to improve AE recognition, prevention, and management.Breaking the Cycle: Prioritizing Weight Loss to Improve OSA Management
https://reachmd.com/programs/cme/breaking-the-cycle-prioritizing-weight-loss-to-improve-osa-management/48715/On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strategies for prioritizing weight loss to improve OSA management among select patients.Inside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
https://reachmd.com/programs/cme/inside-the-cataracts-studio-advanced-fluidics-ergonomics-and-techniques-for-complex-cases-introducing-robotic-slacs/33177/Explore SLACS for cataract surgery, which features a robotic femtosecond laser integrated into the operating suite that can be utilized for complex cases.Updates in Major Depressive Disorder with Insomnia
https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/Join us to learn about the emerging data in the management of major depressive disorder with insomnia.